Komatsu Masayasu, Takahashi Jun, Fukuda Koji, Takagi Yusuke, Shiroto Takashi, Nakano Makoto, Kondo Masateru, Tsuburaya Ryuji, Hao Kiyotaka, Nishimiya Kensuke, Nihei Taro, Matsumoto Yasuharu, Ito Kenta, Sakata Yasuhiko, Miyata Satoshi, Shimokawa Hiroaki
From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Circ Arrhythm Electrophysiol. 2016 Sep;9(9). doi: 10.1161/CIRCEP.115.003798.
Optimal therapy for patients resuscitated from out-of-hospital cardiac arrest (OHCA) who are not found to have structural heart disease remains to be established, especially regarding the use of implantable cardioverter-defibrillators. Coronary artery spasm (CAS) and lethal ventricular arrhythmias are important causes of OHCA.
In 47 consecutive OHCA survivors without structural heart disease who had fully recovered (M/F 44/3, 43±13 years.), we performed dual induction tests, including acetylcholine provocation test first followed by programmed ventricular stimulation after 1 to 2 weeks. Patients with CAS were treated with calcium channel blocker-based antianginal medications; implantable cardioverter-defibrillators were implanted in all patients. The results of the dual induction tests defined 4 groups: CAS alone (n=7), inducible ventricular arrhythmias alone (n=13), both positive (n=24), and both negative (n=3). During a median follow-up period of 38 months, ventricular fibrillation recurred in all groups except the both-negative group. Of the 16 patients with a type I Brugada ECG, 2 had CAS alone, 8 had ventricular arrhythmias alone, and 6 had both positive. No ventricular fibrillation episodes were observed in the CAS-alone patients who did not also have Brugada syndrome. Kaplan-Meier analysis showed that the CAS-alone group was at lower risk for OHCA recurrence as compared with the Brugada syndrome group (log-rank test; P=0.036).
Among OHCA survivors without structural heart disease, provokable CAS and ventricular arrhythmias are common and can be seen in Brugada syndrome. CAS alone without Brugada syndrome who are treated for CAS may be a lower-risk group.
对于院外心脏骤停(OHCA)复苏成功且未发现有结构性心脏病的患者,最佳治疗方案仍有待确定,尤其是在植入式心脏复律除颤器的使用方面。冠状动脉痉挛(CAS)和致命性室性心律失常是OHCA的重要原因。
在47例连续的无结构性心脏病且已完全康复的OHCA幸存者中(男/女44/3,年龄43±13岁),我们进行了双重诱发试验,首先进行乙酰胆碱激发试验,1至2周后再进行程序心室刺激。CAS患者接受基于钙通道阻滞剂的抗心绞痛药物治疗;所有患者均植入了植入式心脏复律除颤器。双重诱发试验结果将患者分为4组:单纯CAS组(n = 7)、单纯可诱发室性心律失常组(n = 13)、两者均阳性组(n = 24)和两者均阴性组(n = 3)。在中位随访期38个月期间,除两者均阴性组外,其他各组均有室颤复发。在16例I型Brugada心电图患者中,2例为单纯CAS,8例为单纯室性心律失常,6例两者均阳性。在未合并Brugada综合征的单纯CAS患者中未观察到室颤发作。Kaplan-Meier分析显示,与Brugada综合征组相比,单纯CAS组OHCA复发风险较低(对数秩检验;P = 0.036)。
在无结构性心脏病的OHCA幸存者中,可诱发的CAS和室性心律失常很常见,且在Brugada综合征中也可见到。未合并Brugada综合征的单纯CAS患者经CAS治疗后可能是低风险组。